An experiment on breast tumor has shown genistein administration (2 μM or 40 nM) stimulates PI3K/Akt and MEK/ERK molecular pathways to induce differentiation of CSCs in breast cancer [195]. The gene discussed is AKT1; the disease is breast cancer.